Sort
64,565 grants matching “drug discovery”
Countermeasures for Bioterroism Targeting Cellular Host Factors
$760,000John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2008 · AI
Project 1: Translational Science of Alopecia Areata
$760,000Angela M Christiano · Columbia University Health Sciences · P50 · FY2016 · AR
BIOACTIVE AGENTS FROM DRYLAND BIODIVERSITY OF LATIN AMER
$760,000University Of Arizona · U01 · FY2001 · TW
Therapy Development for Genetic Disorders of the RAS/MAPK Pathway
$759,920Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL
A diabetes pill to replace insulin injections
$759,882Ilyas Washington · Bioorg3.14, Llc · R44 · FY2020 · DK
4/4 The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomes
$759,778Matthew W State · University Of California, San Francisco · U01 · FY2013 · MH
GInAS - Global Ingredient Archival System
$759,590Noel Southall · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
$759,429Susan Bates · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Optimization of Atypical Antimycobacterial Carbapenem Antibiotics
$759,402John D Buynak · Southern Methodist University · R01 · FY2023 · AI
Discovery of Addiction-Related Genes with Advanced Mouse Resources
$759,397Elissa J Chesler · Jackson Laboratory · R01 · FY2015 · DA
Discovery of Addiction-Related Genes with Advanced Mouse Resources
$759,397Elissa J Chesler · Jackson Laboratory · R01 · FY2017 · DA
Development of nonhuman primate reference transcriptome resources
$759,371Michael G Katze · University Of Washington · R24 · FY2014 · OD
Investigational Cancer Therapeutics Training Program
$759,367Alexander Drilon · Sloan-Kettering Inst Can Research · T32 · FY2023 · CA
SBIR Phase II: The Data Context Map
$759,343Eric Papenhausen · Akai Kaeru, Llc · · FY2019 · TIP
Molecular Targets COBRE
$759,342Donald M Miller · University Of Louisville · P20 · FY2009 · RR
Development of small molecule inhibitors of metabolic enzymes as broad spectrum anthelmintic drugs
$759,307Makedonka Mitreva · Washington University · R01 · FY2024 · AI
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
$759,291Mark W Albers · Massachusetts General Hospital · R01 · FY2020 · AG
NEW CHEMICAL ENTITIES AND UNIQUE TARGETS FOR HCMV
$759,215University Of Michigan At Ann Arbor · P01 · FY2001 · AI
Imaging the Invisible with No Labels: A Major Opportunity in Biology and Medicine
$759,192Xiaoliang Sunney Xie · Harvard University · R01 · FY2013 · EB
Drug Repurposing Screening for Zika Virus Infection
$759,021Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Expanding the use of Tetrahymena as a protein expression platform
$758,950Paul Colussi · Tetragenetics, Inc. · R44 · FY2016 · GM
Indiana University Center for Pediatric Pharmacology
$758,925Jamie L Renbarger · Indiana University Indianapolis · U54 · FY2015 · HD
Automated Droplet Monitoring System
$758,909David Kynor · Creare, Llc · N44 · FY2016 · DA
Uncovering novel biological processes and pathogenic mechanisms for glaucoma
$758,889Ayellet Vered Segre · Massachusetts Eye And Ear Infirmary · R01 · FY2024 · EY
Genetics and Mechanisms of Mitral Valve Prolapse
$758,841David J Milan · Massachusetts General Hospital · R01 · FY2017 · HL